[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Kymera Therapeutics, Inc. Common Stock (KYMR)

Kymera Therapeutics stock surges on positive Phase 1b trial results for KT-621, but a proposed $XXX million share offering introduces a dilutive factor.

### About Kymera Therapeutics, Inc. Common Stock
Kymera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for immuno-inflammatory diseases.  
Kymera Therapeutics, Inc. Common Stock uses the ticker $KYMR for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Kymera Therapeutics, Inc. Common Stock (KYMR) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Kymera Therapeutics, Inc. Common Stock (KYMR) mentions hit 1024 which is XXX% higher than it's daily average.
- Kymera Therapeutics, Inc. Common Stock (KYMR) engagements hit 462.4K which is 3906% higher than it's daily average.
- Kymera Therapeutics, Inc. Common Stock (KYMR) creators hit XXX which is XXX% higher than it's daily average.
- Kymera Therapeutics, Inc. Common Stock (KYMR) trading volume is up XXXXXX% from the previous week.
- Kymera Therapeutics, Inc. Common Stock (KYMR) market cap is up XXXXXX% from the previous year.
- Kymera Therapeutics, Inc. Common Stock (KYMR) social dominance is up 3477.78% from the previous week.
- Kymera Therapeutics, Inc. Common Stock (KYMR) creators is up XXXXXX% from the previous week.
- Kymera Therapeutics, Inc. Common Stock (KYMR) engagements is up 1147.17% from the previous week.
- Kymera Therapeutics, Inc. Common Stock (KYMR) mentions is up XXXXXX% from the previous week.
- Kymera Therapeutics, Inc. Common Stock (KYMR) posts created is up 5812.5% from the previous week.
- Kymera Therapeutics, Inc. Common Stock Engagements hit a 52-Week high of XXXXXXX for the day
- Kymera Therapeutics, Inc. Common Stock Engagements hit an all time of XXXXXXX for the day
- Kymera Therapeutics, Inc. Common Stock Price hit a 52-Week high of $XXXXXX for the hour
- Kymera Therapeutics, Inc. Common Stock Price hit an all time of $XXXXXX for the hour

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/close.tsv)  
The stock price has reached a 52-week and all-time high, driven by positive analyst upgrades, increased social media engagement, and new preclinical data for KT-579. A significant increase in trading volume and social dominance further bolsters this upward trend, though a proposed share offering may temper immediate gains.  

24-Hour: -XXXX%
7-Day: XXXXX%
30-Day: XXXXX%

1-Year High: $XXXXX on 2025-12-08  
1-Year Low: $XXXXX on 2025-04-08  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/alt_rank.tsv)  
Kymera Therapeutics, Inc. Common Stock (KYMR) is currently AltRank #275 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XX -XXXXX  
X Month: XX -XXXXX  
X Months: XX -XXXXX  
X Year: XX -XXX  
1-Year High: XXXXX on 2025-08-06  
1-Year Low: XX on 2025-01-11  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX no change  
X Month: XX +17  
X Months: XX +7  
X Year: XX -X  
1-Year High: XX on 2025-01-14  
1-Year Low: X on 2025-08-06  
  
  
### Engagements: XXXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/interactions.tsv)  
Current Value: XXXXXXX  
Daily Average: XXXXXX  
X Week: XXXXXXX +1,147%  
X Month: XXXXXXXXX +715%  
X Months: XXXXXXXXX +68%  
X Year: XXXXXXXXX +133%  
1-Year High: XXXXXXX on 2025-12-09  
1-Year Low: XXX on 2025-02-03  

Engagements by network (24h):
News: XXXXX
Reddit: XX
TikTok: XXX
X: XXXXXXX
YouTube: XX

  
  
### Mentions: XXXXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/posts_active.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XXXXX +336%  
X Month: XXXXX +262%  
X Months: XXXXX +263%  
X Year: XXXXX +327%  
1-Year High: XXXXX on 2025-07-06  
1-Year Low: XX on 2025-01-28  

Mentions by network (24h):
News: XX
Reddit: XX
TikTok: XX
X: XXXXX
YouTube: XX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Kymera Therapeutics, Inc. Common Stock (KYMR) in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XX  
X Week: XXX +539%  
X Month: XXX +404%  
X Months: XXXXX +441%  
X Year: XXXXX +331%  
1-Year High: XXX on 2025-07-06  
1-Year Low: X on 2025-01-28  

The most influential creators that mention Kymera Therapeutics, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@A_May_MD](/creator/twitter/A_May_MD)               | X    | XXXXXX    | X     | XXXXXX      |
| [@semodough](/creator/twitter/semodough)             | X    | XXXXXX    | X     | XXXXXX      |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | X    | XXXXX     | XX    | XXXXXX      |
| [@tenet_research](/creator/twitter/tenet_research)   | X    | XXXXXXX   | X     | XXXXX       |
| [@Pharmdca](/creator/twitter/Pharmdca)               | X    | XXXXXXX   | X     | XXXXX       |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | X    | XXXXXX    | XX    | XXXXX       |
| [@DeepSouthDoctor](/creator/twitter/DeepSouthDoctor) | X    | XXXXX     | X     | XXXXX       |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | X    | XXXXX     | X     | XXXXX       |
| [@Banana_Oncology](/creator/twitter/Banana_Oncology) | X    | XXXXX     | X     | XXXXX       |
| [@BioStocks](/creator/twitter/BioStocks)             | XX   | XXXXXX    | X     | XXXXX       |

[View More](/list/creators/$kymr/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% +49%  
X Months: XX% +13%  
X Year: XX% +55%  
1-Year High: XXX% on 2025-01-30  
1-Year Low: XX% on 2025-04-13  

Most Supportive Themes:
- Positive Analyst Commentary and Biotech Sector Outlook: (40%) Analysts are discussing Kymera's approach and comparing it to competitors, with positive sentiment around the biotech sector.
- Mentions of KYMR in conjunction with other Biotech Stocks: (30%) Posts frequently mention KYMR alongside other biotech stocks, indicating potential sector-wide interest and comparisons.
- Positive Sentiment and High Engagement on Social Media: (20%) Overall sentiment is positive, with high engagement on posts mentioning KYMR, especially from influential creators.
  
Most Critical Themes:
- Concerns about Efficacy and Side Effects: (10%) Some posts raise concerns about the efficacy of KYMR's treatments compared to competitors and potential side effects.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.094%  
X Month: XXXXX% +0.137%  
X Months: XXXXX% +0.126%  
X Year: XXXXX% +0.133%  
1-Year High: XXXXX% on 2025-07-06  
1-Year Low: XXXXXX% on 2025-04-08  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-12-08  
1-Year Low: XXXXXXX% on 2025-03-19  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$kymr/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$kymr/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$35%  
X Month: $XXXXXXXXXXXXX +$48%  
X Months: $XXXXXXXXXXXXX +$103%  
X Year: $XXXXXXXXXXXXX +$121%  
1-Year High: $XXXXXXXXXXXXX on 2025-12-08  
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08  

### Top Kymera Therapeutics, Inc. Common Stock News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Kymera Therapeutics stock price target raised to $XXX from $XX at Stifel By Investing.com"  
[News Link](https://www.investing.com/news/analyst-ratings/kymera-therapeutics-stock-price-target-raised-to-114-from-68-at-stifel-93CH-4396613) [@Investingcom](/creator/x/Investingcom) 2025-12-08T22:11Z 1.4M followers, XXX engagements


"Kymera Rockets Pulling Nurix Higher. Does It Have The Next Dupixent"  
[News Link](https://finance.yahoo.com/m/e4eadc66-e1c4-303f-ae66-5862fa83f1fb/kymera-rockets%2C-pulling-nurix.html) [@YahooFinance](/creator/x/YahooFinance) 2025-12-08T19:02Z 228.6M followers, XX engagements


"Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis"  
[News Link](https://finance.yahoo.com/news/kymera-therapeutics-announces-positive-results-120000675.html) [@YahooFinance](/creator/x/YahooFinance) 2025-12-08T12:06Z 228.6M followers, 19.3K engagements



### Top Kymera Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Kymera Therapeutics reported that for the second time this year it has succeeded in an early-stage trial of a closely watched drug meant to rival Sanofi and Regenerons blockbuster therapy Dupixent"  
[X Link](https://x.com/statnews/status/1998498385389609409) [@statnews](/creator/x/statnews) 2025-12-09T21:02Z 160K followers, 1759 engagements


"Buy Signal Kymera Therapeutics Inc - X Dec 2025 @ 15:47 - USD86.55"  
[Reddit Link](https://redd.it/1piivht) [@jvc72](/creator/reddit/jvc72) 2025-12-09T20:59Z X followers, X engagements


"ive got a good feeling about $VERV and $RNA. im thinking $LLY and $NVS"  
[X Link](https://x.com/PersimmonTI/status/1998484020724904215) [@PersimmonTI](/creator/x/PersimmonTI) 2025-12-09T20:04Z 10.5K followers, 5833 engagements


"Stocks with latest insider transactions: $ALMU $EOSE $DVLT $SYM $SERA $GSAT $HOPE $KYMR $PTC $CNTA $ALHC $REXR $UWMC $NPWR $UMBF $NPWR"  
[Reddit Link](https://redd.it/1pid5gv) [@SolongLife](/creator/reddit/SolongLife) 2025-12-09T17:20Z X followers, XX engagements